Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. is a leading biotechnology company engaged in the discovery, development, and commercialization of innovative medicines. The company's primary function is to address unmet medical needs through its robust research and development efforts, focusing on a broad range of therapeutic areas, including ophthalmology, oncology, immunology, and infectious diseases. Regeneron is particularly noted for its monoclonal antibody therapies and is a prominent player in the global biopharmaceutical industry. The company's products, such as those for treating eye diseases and certain cancers, have significant impacts on both healthcare providers and patients. Headquartered in Tarrytown, New York, Regeneron collaborates with various pharmaceutical companies and academia to enhance its research capabilities and bring novel therapies to market, underscoring its crucial role in advancing medical science and improving global health outcomes.